The FDA has received 70,962 adverse event reports for dogs that name Sarolaner.
- 70,962 reports name Sarolaner in dogs, which is 7.1% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 51% are marked serious and 2.1% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 49% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, lack of efficacy (bacteria) - borrelia and seizure.
- The FDA lists 2 approved animal drug applications containing Sarolaner for dogs, the earliest approved in 2016.
- None of this is a rate. The FDA data does not record how many dogs were given Sarolaner, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 35,836 | 51% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 1,511 | 2.1% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 34,514 | 49% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 7,710 | 11% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 15,220 | 21% | 21% |
Where on the body do the reported signs sit?
Not on the body: Did not work 43% Whole body 6.6% How it was given 4.9%
- Did not work43%lack of efficacy (bacteria) - borrelia, lack of efficacy (endoparasite) - heartworm, lack of efficacy (endoparasite) - hookworm, lack of efficacy (ectoparasite) - tick and 6 more
- Stomach and gut28%vomiting, diarrhoea, not eating, anorexia and 2 more
- Brain and nerves15%seizure, tremor, ataxia, shaking
- Whole body6.6%lethargy, lethargy
- How it was given4.9%intentional misuse, medication error
- Behaviour1.5%behavioural disorder
Each figure is a share of sign mentions among the 25 signs reported most for Sarolaner in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting13,289 19%
- Lack of efficacy (bacteria) - Borrelia7,194 10%
- Seizure7,181 10%
- Lack of efficacy (endoparasite) - heartworm6,380 9.0%
- Diarrhoea5,422 7.6%
- Lack of efficacy (endoparasite) - hookworm4,640 6.5%
- Lack of efficacy (ectoparasite) - tick4,376 6.2%
- Lethargy3,558 5.0%
Reports received per year
Is it approved for dogs?
The FDA lists 2 approved animal drug applications containing Sarolaner for dogs, the earliest approved in 2016.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Sarolaner in cats (8,530 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Fluralaner in dogs68,773
- Afoxolaner in dogs65,969
- Moxidectin in dogs76,891
- Praziquantel in dogs59,564
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.